)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
GIANT BIOGENE
GIANT BIOGENE (2367) investor relations material
GIANT BIOGENE H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary18 Aug, 2026
Executive summary
Revenue for H1 2026 was RMB2,917.7 million, down 6.3% year-over-year, mainly due to sales restructuring and intensified competition.
Net profit was RMB939.5 million, a 20.5% decrease year-over-year; adjusted net profit fell 21.5%.
The company continued to invest in R&D, launching innovative products, expanding its patent portfolio, and building its brand.
Direct sales accounted for 76.6% of revenue, with online DTC stores contributing the majority.
Financial highlights
Gross profit was RMB2,318.4 million (down 8.8% YoY); gross margin declined from 81.7% to 79.5%.
Net profit: RMB939.5 million (down 20.5% YoY).
Basic EPS: RMB0.89 (down 21.9% YoY).
Cash and cash equivalents: RMB4,852.5 million (down 23.1% from Dec 2025).
Selling and distribution expenses rose 19.7% to RMB1,266.8 million.
Outlook and guidance
Management expects a return to growth in H2 2026, focusing on R&D, industrialization of new materials, and expansion of core brands and global presence.
Plans to deepen online self-operated platforms, strengthen offline networks, and expand internationally.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from GIANT BIOGENE
- Flat revenue and lower profit in 2025 amid competition, with strong cash and continued R&D investment.2367
H2 2025 - Strong revenue and profit growth with robust cash position and expanded brand presence.2367H1 2025
- Revenue and net profit surged on robust brand and omni-channel growth; gross margin eased.2367H1 2024
- Revenue and profit soared on strong brand and channel growth; major dividends proposed.2367H2 2024
Next GIANT BIOGENE earnings date
H2 202618 Mar, 2027
GIANT BIOGENE
Next GIANT BIOGENE earnings date
H2 202618 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Giant Biogene Holding Co., Ltd. is a China-based biotechnology company specializing in the development, production, and sale of functional skincare products. Its products are tailored for both medical and consumer markets, focusing on skin health, repair, and rejuvenation. The company is headquartered in Xi'an, China, and its shares are listed on the Hong Kong Stock Exchange.